We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

140 hedge funds and large institutions have $1.22B invested in Alder Biopharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 35 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 35

74% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 19

10% more funds holding

Funds holding: 127 → 140 (+13)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

28% less capital invested

Capital invested by funds: $1.69B → $1.22B (-$471M)

73% less call options, than puts

Call options by funds: $2.4M | Put options by funds: $8.78M

Holders
140
Holders Change
+13
Holders Change %
+10.24%
% of All Funds
3.91%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
33
Increased
62
Reduced
35
Closed
19
Calls
$2.4M
Puts
$8.78M
Net Calls
-$6.37M
Net Calls Change
-$2.55M

Top Buyers

1
JHIU
Janus Henderson Investors US
Colorado
+$144M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$26.3M
3
SAM
Senzar Asset Management
New York
+$23.4M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$15.7M
5
EAM
EverPoint Asset Management
Connecticut
+$15.7M

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$103M
2
BBA
Baker Bros. Advisors
New York
-$16.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$14M
4
EAM
Eagle Asset Management
Florida
-$9.64M
5
PC
PointState Capital
New York
-$7.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
76
New York State Common Retirement Fund
New York
$786K +$128K +3,001 +14%
SO
77
STRS Ohio
Ohio
$776K +$140K +3,300 +16%
Simplex Trading
78
Simplex Trading
Illinois
$764K +$904K +21,268 +1,023%
PIM
79
Partner Investment Management
California
$751K +$204K +4,792 +26%
DekaBank Deutsche Girozentrale
80
DekaBank Deutsche Girozentrale
Germany
$711K +$140K +3,300 +18%
ACH
81
ArrowMark Colorado Holdings
Colorado
$709K -$34.4K -808 -4%
TAM
82
Tocqueville Asset Management
New York
$708K +$345K +8,125 +60%
Citigroup
83
Citigroup
New York
$699K +$593K +13,944 +189%
Stifel Financial
84
Stifel Financial
Missouri
$691K +$727K +17,100 New
PCM
85
Pyrrho Capital Management
New York
$677K +$878K +20,657 New
RhumbLine Advisers
86
RhumbLine Advisers
Massachusetts
$673K +$123K +2,885 +16%
Allianz Asset Management
87
Allianz Asset Management
Germany
$625K -$149K -3,500 -16%
Tudor Investment Corp
88
Tudor Investment Corp
Connecticut
$590K +$214K +5,035 +39%
DCM
89
DAFNA Capital Management
California
$590K +$765K +18,000 New
EI
90
EAM Investors
California
$575K -$205K -4,812 -22%
AP
91
AlpInvest Partners
Netherlands
$564K +$732K +17,213 New
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$547K – – –
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$541K +$83.4K +1,962 +13%
OM
94
Opaleye Management
Massachusetts
$527K +$684K +16,100 New
TC
95
TFS Capital
Pennsylvania
$503K -$173K -4,063 -21%
NFA
96
Nationwide Fund Advisors
Ohio
$489K +$67.3K +1,584 +12%
D.E. Shaw & Co
97
D.E. Shaw & Co
New York
$463K -$153K -3,594 -20%
RFC
98
Russell Frank Company
Washington
$459K -$234K -5,499 -28%
SEI Investments
99
SEI Investments
Pennsylvania
$418K +$461K +10,832 +564%
AIG
100
American International Group
New York
$397K +$595 +14 +0.1%
2 3
4
5 6

ALDR Hedge Fund Activity: Q3 2015 in Review

140 of the 3,581 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q3 2015, worth a combined $1.22B — down 28% from $1.69B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ALDR positions and 19 closed out — a net gain of 14 holders — while 62 added to existing stakes and 35 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $144M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $103M sold.

  • 140 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q3 2015, up from 127 in Q2 2015.
  • Funds reported $1.22B of Alder Biopharmaceuticals stock for Q3 2015, down 28% quarter-over-quarter.
  • 33 funds opened new Alder Biopharmaceuticals positions in Q3 2015 and 19 closed out, a net change of +14 holders.
  • The largest Alder Biopharmaceuticals buyer in Q3 2015 was Janus Henderson Investors US, an estimated $144M added.
  • The largest Alder Biopharmaceuticals seller in Q3 2015 was Novo Holdings A/S, an estimated $103M sold.

Based on aggregated 13F filings for Q3 2015.